FDA proposes adding 'race and ethnicity' category to expanded access requests
It’s well understood that racial and ethnic minorities often lack access to clinical trials in the US, either because of restricted inclusion/exclusion criteria or because …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
